Keel Point’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.11M Buy
10,134
+1,645
+19% +$667K 0.27% 66
2025
Q1
$4.22M Sell
8,489
-36
-0.4% -$17.9K 0.33% 59
2024
Q4
$4.44M Buy
8,525
+272
+3% +$142K 0.35% 50
2024
Q3
$5.11M Buy
8,253
+182
+2% +$113K 0.43% 36
2024
Q2
$4.88M Sell
8,071
-557
-6% -$337K 0.44% 36
2024
Q1
$5.01M Buy
8,628
+333
+4% +$194K 0.52% 35
2023
Q4
$4.4M Buy
8,295
+1,243
+18% +$660K 0.53% 33
2023
Q3
$3.57M Sell
7,052
-123
-2% -$62.3K 0.49% 38
2023
Q2
$3.74M Sell
7,175
-342
-5% -$178K 0.5% 44
2023
Q1
$4.33M Sell
7,517
-57
-0.8% -$32.9K 0.63% 28
2022
Q4
$4.17M Sell
7,574
-124
-2% -$68.3K 0.65% 28
2022
Q3
$3.9M Buy
7,698
+47
+0.6% +$23.8K 0.67% 30
2022
Q2
$4.53M Buy
7,651
+275
+4% +$163K 0.71% 28
2022
Q1
$4.36M Buy
7,376
+347
+5% +$205K 0.65% 33
2021
Q4
$4.69M Sell
7,029
-101
-1% -$67.4K 0.53% 35
2021
Q3
$4.07M Buy
7,130
+145
+2% +$82.9K 0.53% 35
2021
Q2
$3.52M Buy
6,985
+735
+12% +$371K 0.39% 50
2021
Q1
$2.85M Buy
6,250
+270
+5% +$123K 0.28% 60
2020
Q4
$2.79M Buy
5,980
+559
+10% +$260K 0.25% 68
2020
Q3
$2.39M Buy
5,421
+625
+13% +$276K 0.22% 61
2020
Q2
$1.74M Buy
4,796
+87
+2% +$31.5K 0.18% 61
2020
Q1
$1.34M Sell
4,709
-213
-4% -$60.4K 0.17% 57
2019
Q4
$1.6M Buy
4,922
+800
+19% +$260K 0.17% 58
2019
Q3
$1.2M Buy
4,122
+195
+5% +$56.8K 0.15% 70
2019
Q2
$1.15M Buy
3,927
+345
+10% +$101K 0.13% 69
2019
Q1
$980K Buy
3,582
+463
+15% +$127K 0.11% 69
2018
Q4
$698K Buy
3,119
+1,764
+130% +$395K 0.09% 88
2018
Q3
$331K Buy
1,355
+173
+15% +$42.3K 0.04% 138
2018
Q2
$245K Buy
1,182
+70
+6% +$14.5K 0.03% 145
2018
Q1
$230K Buy
+1,112
New +$230K 0.03% 142